Wolverine Trading, LLC Chemo Centryx, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$15.36 - $27.51 $219,648 - $393,393	-14,300 Reduced 21.97%	50,800 $1.3 Million
Q1 2022 May 16, 2022	BUY	$22.22 - $39.12 $1.45 Million - $2.55 Million	65,100 New	65,100 $1.63 Million
Q4 2021 Feb 14, 2022	SELL	$18.38 - $40.5 $3.82 Million - $8.42 Million	-207,900 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$13.18 - $19.83 $1.46 Million - $2.2 Million	110,900 Added 114.33%	207,900 $4.07 Million
Q2 2021 Aug 06, 2021	BUY	$9.59 - $50.88 $930,230 - $4.94 Million	97,000 New	97,000 $1.37 Million

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.